Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory ...
If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced topline results from the Phase 3 ...
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed ...
Presented by Alliance for Aging Research{beacon} Health Care Health Care PRESENTED BY The Big Story Pfizer’s Lyme disease ...
An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday; ...
Approximately 476,000 people are diagnosed and treated for Lyme disease each year in the United States,” according to the ...
Emily Zoladz knew something was wrong with her son, Issac, when the then-6 year old began limping up the stairs. He had been ...
Spring may have sprung, but you don’t want any ticks springing on your body this season. As the weather starts to get warmer, ...
21dOpinion
Lyme disease patients turn elsewhere because medicine has failed them (Guest Opinion by Holly Ahern)
Microbiology research responds to medical student's critique of unproven alternative treatments. One-size-fits-all medical ...
The candidate showed 73.2% efficacy after the fourth and final dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results